Adage Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.95M | Buy |
534,000
+50,000
| +10% | +$838K | 0.02% | 639 |
|
|
2025
Q1 | $7.44M | Sell |
484,000
-716,000
| -60% | -$11M | 0.01% | 639 |
|
|
2024
Q4 | $26.4M | Sell |
1,200,000
-2,421,899
| -67% | -$53.4M | 0.05% | 364 |
|
|
2024
Q3 | $65.3M | Buy |
3,621,899
+1,518,733
| +72% | +$27.4M | 0.12% | 191 |
|
|
2024
Q2 | $34.2M | Buy |
2,103,166
+1,576,166
| +299% | +$25.6M | 0.06% | 302 |
|
|
2024
Q1 | $7.44M | Hold |
527,000
| – | – | 0.01% | 647 |
|
|
2023
Q4 | $5.5M | Buy |
+527,000
| New | +$5.5M | 0.01% | 671 |
|
|
2017
Q4 | – | Sell |
-250,000
| Closed | -$4.4M | – | 748 |
|
|
2017
Q3 | $4.4M | Buy |
+250,000
| New | +$4.4M | 0.01% | 633 |
|